The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Zebbo the trials have most likely ended already do you think there will be be any provisional results before August? The RNS suggested that there would be provisional data available in July
Madrigal Pharmaceuticals Inc. shares soared as much as 145% in extremely heavy Thursday trade after the company released positive results for a phase 2 clinical trial for a type of liver disease called non-alcoholic steatohepatitis, or NASH.